These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17310277)
1. Telomeres and telomerase as targets for cancer therapy. Zimmermann S; Martens UM Cell Mol Life Sci; 2007 Apr; 64(7-8):906-21. PubMed ID: 17310277 [TBL] [Abstract][Full Text] [Related]
2. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer. Sekhri K J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374 [TBL] [Abstract][Full Text] [Related]
3. Telomerase inhibitors in cancer therapy: current status and future directions. Incles CM; Schultes CM; Neidle S Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225 [TBL] [Abstract][Full Text] [Related]
4. Targeting the telosome: therapeutic implications. Folini M; Gandellini P; Zaffaroni N Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699 [TBL] [Abstract][Full Text] [Related]
5. Telomere and telomerase as targets for anti-cancer and regeneration therapies. Hsu YH; Lin JJ Acta Pharmacol Sin; 2005 May; 26(5):513-8. PubMed ID: 15842766 [TBL] [Abstract][Full Text] [Related]
6. Telomere inhibition and telomere disruption as processes for drug targeting. Rezler EM; Bearss DJ; Hurley LH Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745 [TBL] [Abstract][Full Text] [Related]
7. Tackling cancer at the telomeres. Marx J Science; 2002 Mar; 295(5564):2350. PubMed ID: 11923505 [No Abstract] [Full Text] [Related]
8. Telomere maintenance as a target for drug discovery. Sekaran V; Soares J; Jarstfer MB J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596 [TBL] [Abstract][Full Text] [Related]
9. Is telomerase a viable target in cancer? Buseman CM; Wright WE; Shay JW Mutat Res; 2012 Feb; 730(1-2):90-7. PubMed ID: 21802433 [TBL] [Abstract][Full Text] [Related]
10. Agents that target telomerase and telomeres. Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642 [TBL] [Abstract][Full Text] [Related]
11. Anticancer therapy targeting telomeres and telomerase : current status. Parkinson EK; Minty F BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621 [TBL] [Abstract][Full Text] [Related]
12. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs]. Raymond E; Faivre S; Dieras V; Von Hoff D Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365 [TBL] [Abstract][Full Text] [Related]
13. Telomeres and telomerase as targets for anticancer drug development. Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501 [TBL] [Abstract][Full Text] [Related]
15. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747 [TBL] [Abstract][Full Text] [Related]
16. [Are telomeres and telomerase still relevant targets in oncology?]. Mergny JL; Guittat L; Ségal-Bendirdjian É Bull Cancer; 2021 Jan; 108(1):30-38. PubMed ID: 33256968 [No Abstract] [Full Text] [Related]
17. Oligonucleotides Targeting Telomeres and Telomerase in Cancer. Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661 [TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerase: Pharmacological targets for new anticancer strategies? Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544 [TBL] [Abstract][Full Text] [Related]
19. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches. Salimi-Jeda A; Badrzadeh F; Esghaei M; Abdoli A Cancer Treat Res Commun; 2021; 27():100323. PubMed ID: 33530025 [TBL] [Abstract][Full Text] [Related]
20. Telomerase: a target for cancer therapeutics. Shay JW; Wright WE Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]